293 related articles for article (PubMed ID: 23375353)
1. Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment.
Stanczyk FZ; Archer DF; Bhavnani BR
Contraception; 2013 Jun; 87(6):706-27. PubMed ID: 23375353
[TBL] [Abstract][Full Text] [Related]
2. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation.
Bastianelli C; Farris M; Rosato E; Brosens I; Benagiano G
Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1085-1098. PubMed ID: 30325245
[TBL] [Abstract][Full Text] [Related]
4. A new contraceptive pill containing 17β-estradiol and nomegestrol acetate.
Christin-Maitre S; Laroche E; Bricaire L
Womens Health (Lond); 2013 Jan; 9(1):13-23. PubMed ID: 23241152
[TBL] [Abstract][Full Text] [Related]
5. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
[TBL] [Abstract][Full Text] [Related]
6. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
Davis SR; Bitzer J; Giraldi A; Palacios S; Parke S; Serrani M; Mellinger U; Nappi RE
J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
[TBL] [Abstract][Full Text] [Related]
7. Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives.
Hoffmann H; Moore C; Zimmermann H; Elger W; Schwarz S; Gräser T; Oettel M
Exp Toxicol Pathol; 1998 Sep; 50(4-6):458-64. PubMed ID: 9784023
[TBL] [Abstract][Full Text] [Related]
8. The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction.
Roumen FJ; Mishell DR
Eur J Contracept Reprod Health Care; 2012 Dec; 17(6):415-27. PubMed ID: 23113828
[TBL] [Abstract][Full Text] [Related]
9. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
Benagiano G
Int J Fertil; 1989 Sep; 34 Suppl():31-9. PubMed ID: 2576255
[TBL] [Abstract][Full Text] [Related]
11. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
[TBL] [Abstract][Full Text] [Related]
12. Estradiol valerate/dienogest: a novel combined oral contraceptive.
Borgelt LM; Martell CW
Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
[TBL] [Abstract][Full Text] [Related]
13. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.
Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G
Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with a new norgestimate-containing oral contraceptive.
Huber J
Int J Fertil; 1991; 36 Suppl 1():25-31. PubMed ID: 1678378
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe).
Nakajima ST; Archer DF; Ellman H
Contraception; 2007 Jan; 75(1):16-22. PubMed ID: 17161118
[TBL] [Abstract][Full Text] [Related]
17. Current perspectives on combination oral contraceptives.
Smith MA; Youngkin EQ
Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
[TBL] [Abstract][Full Text] [Related]
18. Gestodene: a review of its pharmacology, potency and tolerability in combined contraceptive preparations.
Stanczyk FZ; Archer DF
Contraception; 2014 Apr; 89(4):242-52. PubMed ID: 24485094
[TBL] [Abstract][Full Text] [Related]
19. Tailoring combination oral contraceptives to the individual woman.
Archer DF; Lasa IL
J Womens Health (Larchmt); 2011 Jun; 20(6):879-91. PubMed ID: 21631372
[TBL] [Abstract][Full Text] [Related]
20. Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol.
Torgrimson BN; Meendering JR; Kaplan PF; Minson CT
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2874-80. PubMed ID: 17277029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
